Explore the Full Event Guide to Discover
18 expert speakers from pioneering biotech and pharma companies, including Bristol Myers Squibb, Monument Therapeutics, Click Therapeutics, and 4M Therapeutics.
Two full days of content, plus pre-conference workshops tackling translational models, patient stratification, and clinical trial optimization.
Breakthrough sessions on muscarinic agonists, KCC2 activators, NMDA-targeting therapies, and digital biomarkers.
Exclusive investor and regulatory panels, tackling funding, clinical trial strategy, and commercialization in psychosis drug development.
Interactive roundtables, networking, and a scientific poster session connecting industry leaders to shape the future of psychosis therapeutics.
Download the Full Event Guide:
Having trouble downloading the brochure?
Let us know and we'll email it to you instead
Companies On The Program:
